Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117434) titled 'Targeted Screening of Gut Microbiota Metabolites as Clinical Biomarkers and Their Regulatory Mechanisms in CKD' on Jan. 23.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Shenzhen Hospital of Southern Medical University
Condition:
Chronic kidney disease
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2026-02-28
Target Sample Size: Chronic Kidney Disease:120;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=302166
Published by HT Digital Content Services with permission from Health Daily Digest....